2269.HK vs V5Z: Side-by-Side Comparison
Compare WuXi Biologics (Cayman) Inc. (2269.HK) and Sirnaomics Ltd. (V5Z) side by side: market cap HKD 142.15B vs EUR 55.91M. Financials, growth and model signals on Bullrun.
| Metric | 2269.HK | V5Z |
|---|---|---|
| Company | WuXi Biologics (Cayman) Inc. | Sirnaomics Ltd. |
| Country / Exchange | Hong Kong | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | HKD 142.15B | EUR 55.91M |
| P/E ratio | 25.8 | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | HKD 21.79B | EUR 1.78M |
| Revenue growth YoY | +16.7% | — |
| Net income | HKD 4.91B | EUR -51.38M |
| Gross margin | 46.0% | 67.4% |
| Diluted EPS | 1.16 | -0.66 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.